o2h ventures led an investment into Tay Therapeutics formerly known as In4Derm, a spinout from Dundee University. Tay Therapeutics is an innovative drug discovery company that develops the next generation of topical and oral therapies for widespread inflammatory conditions, such as eczema or rheumatoid arthritis. The company has two projects aimed at oral anti-inflammatory related indications, one which is a licensing discussion with Almirall (topical eczema) and the other which will continue to be developed by the company

Specialize in the discovery of drugs, which are safe and effective, for the treatment of skin diseases including ​eczema, non-melanoma skin cancers and orphan skin diseases
Status Active
Website https://www.in4derm.co.uk/
Category Biotech
Modality Small Molecule
Therapautics Area
Headquaters Dundee, Scotland
Investment Portfolio Fund Investment
Co-Investors Scottish Investment Bank